Fundraising FoxDCI Partners Co. Ltd.
Venture capitalTokyo · Seed–Series A · 4 people tracked
Also known as 大和企業投資株式会社
Find your way into DCI Partners Co. Ltd.
Sign up to see every warm intro you have to DCI Partners Co. Ltd.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the DCI Partners Co. Ltd. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
DCI Partners is a specialized VC focused on drug discovery and regenerative medicine, building on more than 20 years of biotech investing experience dating from its NIF era (now Daiwa Corporate Investment). It operates one of the largest specialized funds of its kind in Japan, supplying risk capital to growth-stage companies poised to shape future industries. Beyond funding, the firm offers hands-on support drawing on expertise in clinical development, intellectual property, and business development, plus networks across research institutions, drug-discovery ventures, and pharmaceutical companies. It also leads the creation of new ventures from promising research seeds and collaborates across Japan and Taiwan to maximize portfolio potential.
Source: firm website, verified Aug 3, 2026.
Team · 4 people
from the firm's website & public directories
What they invest in
from 2 of 2 portfolio companiesHealthtech ×2AI & Machine Learning ×1Biotech ×1Deep Tech ×1Digital Health ×1Longevity ×1Medical Devices ×1
HQs:Japan×2
Investments · 2 tracked
founders shown can be your intro pathBy year:2022 · 12019 · 12 dated
LUCA Science develops mitochondrial therapies that supply functional, storable mitochondria to damaged or dysfunctional cells and tissues to restore cellular energy production, targeting conditions such as ischemia-reperfusion injuries including cerebral and myocardial infarction.
BiotechDeep TechHealthtechLongevity
Co-investorsAsahi Kasei Corporate Venture CapitalFast Track InitiativeRemiges Ventures, Inc.4BIO CapitalAstellas Venture Management LLCAxil Capital
AI Medical Service Inc. develops AI systems that support image-based diagnosis of endoscopy, primarily for detecting gastrointestinal cancers such as stomach and esophageal cancer.
AI & Machine LearningDigital HealthHealthtechMedical DevicesTokyo, JP
Tomohiro Tada(Representative Director & Chief Medical Officer)inYasushi Takikawa(Representative Director)
Co-investorsGlobis Capital PartnersWiLJapan Post Capital Co. Ltd.SoftBank Vision FundSony Ventures Corporation
Frequently asked questions
- What stage does DCI Partners Co. Ltd. invest at?
- DCI Partners Co. Ltd. invests at the Seed, Series A stages.
- What sectors does DCI Partners Co. Ltd. focus on?
- DCI Partners Co. Ltd. focuses on Biotech, Digital Health, Healthtech, Medical Devices, SaaS, Sector Agnostic.
- Where is DCI Partners Co. Ltd. located?
- DCI Partners Co. Ltd. is headquartered in Tokyo, JP.
Images
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Investinor AS is a Norwegian investment company that partners with founders, entrepreneurs and other investors to help selected promising companies become world-leading.
Norwest is a venture capital and growth equity investment firm that has backed over 700 companies across technology, consumer, and healthcare over its 65-year history.
Forward Venture Capital is an early-stage investor that backs and helps accelerate the growth of entrepreneurs, collaborating closely with founders through the investment process.